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1. Background
The increased incidences of localized and systemic 
infections caused by Candida spp. during the past de-
cade have been well documented mainly because of the 
growing numbers of human immunodeficiency virus 
(HIV)-infected immunocompromised individuals, which 
are attributable to the HIV pandemic and increased use 
Background: The incidence of opportunistic infections due to Candida albicans and other 
Candida spp. has been increasing. Rapid identification of candidiasis is important for 
the clinical management of immunocompromised patients. Polymerase chain reaction-
restriction fragment length polymorphism (PCR-RFLP) is a rapid, sensitive, and specific 
method for detection of clinically important fungi. 
Objectives: The purpose of this study was to identify Candida spp. isolated from the oral 
cavities of HIV-infected patients in southeastern Iran (Kerman), by using PCR-based re-
striction enzyme digestion. 
Patients and Methods: We identified 96 Candida isolates obtained from 139 Iranian pa-
tients infected with the human immunodeficiency virus (HIV), between April 2009 and 
April 2010, by using PCR-RFLP assay. Universal primers for the internal transcribed spacer 
(ITS) region (ITS1–ITS4) of the fungal rRNA genes were used for this assay. 
Results: We successfully identified the different Candida spp. by using the restriction en-
zyme MspI. C. albicans was the most commonly identified species (82.2%), followed by C. 
glabrata (7.29%), C. parapsilosis and C. kefyr (both 4.1%), and C. tropicalis (2%).
Conclusions: PCR-RFLP is a highly sensitive, specific, and direct method for fungal detec-
tion and can be used for fungal epidemiological studies in HIV-positive and other im-
munocompromised patients. 
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of immunosuppressive therapy in cancer and organ 
transplant patients. Furthermore, the widespread use of 
broad-spectrum antibiotics and increased use of invasive 
procedures (e.g., intubation) and devices (such as drains 
and catheters) are probably important contributing fac-
tors to the incidences of these infections (1-3).
Infections caused by opportunistic agents such as the 
Candida spp. frequently develop in patients with diverse 
pathological and immunodeficient states such as neutro-
penia, neoplasia, decompensated diabetes mellitus, mal-
nutrition, organ transplantation, and acquired immuno-
deficiency syndrome (AIDS) (4). Oral candidiasis develops 
in 90% of the patients with AIDS, and is the most prevalent 
opportunistic infection in HIV-infected individuals. In ad-
dition, it is an important indicator of disease progression 
and increased immunosuppression (5). The incidences of 
opportunistic infections, oral manifestations of HIV in-
fection, and oral candidiasis decreased after the introduc-
tion of highly active antiretroviral therapy (HAART) (6).
Traditional methods used for the identification and typ-
ing of clinical Candida isolates include morphological 
and biochemical analyses, colony morphotyping, resisto-
gram typing, and serotyping. These techniques are time-
consuming and are dependent on phenotypic expression, 
which makes them potentially unreliable. An alternative 
method of identification could be genotype-based identi-
fication. Genotypic methods have been used extensively 
for the detection and typing of Candida strains, but have 
been used less frequently for species differentiation (7).
2. Objectives
The aim of this study was to identify the 96 Candida spp. 
that were isolated from the oral cavities of 139 HIV-posi-
tive Iranian patients in Kerman between April 2009 to 
April 2010. We used the internal transcribed spacer (ITS) 
sequences (ITS1–ITS4) of various Candida spp. and the re-
striction enzyme MspI for identifying Candida spp. in this 
patient group.
3. Patients and Methods
3.1. Sample Collection and Strain Identification
In this study, 139 samples were obtained from the oral 
cavities of HIV-positive Iranian patients (men, 125; wom-
en, 14) with clinically important lesions of oral candidia-
sis. These patients underwent addiction tests at trian-
gular clinics in a prison in Kerman, between April 2009 
and April 2010. All the patients gave written informed 
consent, and the deputy of the research ethics commit-
tee of Kerman University of Medical Sciences approved 
the study. The oropharyngeal candidiasis (OPC) lesions 
in HIV-infected patients were diagnosed by an infectious-
diseases specialist on the basis of clinical presentation, 
findings of direct microscopic examination, and positive 
culture results. OPC lesion samples were obtained from 
the tongue or the buccal mucosa by using sterile cotton 
swabs. These swabs were incubated in Sabouraud’s dex-
trose agar with choramphenicol (Merck, Germany) at 
32°C for 48 h (under aerobic conditions) and in CHRO-
Magar™ Candida (CHROMagar, France) at 35°C for 48 h (in 
the dark) for production of species-specific colors.
Different chromogenic culture media capable of dis-
tinguishing C. albicans from other clinically important 
yeast strains are commercially available. Such media dis-
tinguish Candida strains from other yeast strains on the 
basis of the color changes produced by the Candida colo-
nies, which are measured using pH indicators and by fer-
mentation of specific compounds or chromogenic sub-
strates for the presumptive identification of C. albicans, C. 
tropicalis, and C. krusei (8). We used a 10% KOH preparation 
and Giemsa stain for microscopic examination of pseu-
dohyphae and yeast cell forms. We used carbohydrate 
assimilation tests with RapID™ Yeast Plus System (Remel, 
USA) according to the manufacturer’s instructions. Fresh 
yeast colonies were incubated with rabbit serum at 37°C 
for 3 h to test for germ tube formation. Development of 
filamentous-form cells and chlamydospore formation 
were evaluated by culturing the yeast isolates on Dalmau 
plates (cornmeal-Tween 80 agar) at 30°C for 48 h (9).
Polymerase chain reaction-restriction fragment length 
polymorphism (PCR-RFLP) was performed using specific 
primers for the molecular identification of Candida spp. 
All the samples were incubated in a medium containing 
4% glucose, 1% peptone, and 1.5% agar and were incubated 
at 37°C for 2 days to ensure proper growth.
3.2. DNA Extraction
Genomic DNA was extracted using the glass bead dis-
ruption method (10, 11).
3.3. PCR Amplification 
The PCR assay was performed using 1 μL of the test sam-
ple (about 1 ng) in a final volume of 50 μL. The PCR mix 
consisted of 10 mM Tris-HCl; master mix 1×; 1.5 mM MgCl2; 
50 mM KCl; 10 mM each of dATP, dCTP, dGTP, and dTTP; 
0.2 mM each of primers (ITS1: 5′-TCC-GTA-GGT-GAA-CCT-
GCG-G-3′ and ITS4: 5′-TCC-TCC-GCT-TAT-TGA-TAT-GC-3′); 
and 1–2 μL of Taq DNA polymerase. Thirty-five cycles of 
amplification were performed in a Progene thermal 
cycler (Techne, England). The initial denaturation was 
performed at 94°C for 5 min; thereafter, each cycle con-
sisted of a denaturation step at 94°C for 30 s, an anneal-
ing step at 50°C for 1 min, an extension step at 72°C for 1 
min, followed by a final extension step at 72°C for 5 min. 
The amplified products were visualized on 1.5% agarose 
gel run in tris-borate-EDTA (TBE) buffer (0.09 M Tris, 0.09 
M boric acid, and 20 mM EDTA; pH 8.3) and stained with 
0.5 μg mL-1 ethidium bromide. The stained gel was photo-
graphed using the Ultra Violet Photography (Integrated 
Vision Products®).
3.4. RFLP Assay 
The ITS1–ITS4 sequences of various Candida spp. were 
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used in this study. On the basis of the sequences, the re-
striction sites of different restriction enzymes were de-
termined by the DNASIS software (Hitachi DNASIS® MAX 
v3.0 Sequence Analysis Software), and the most ideal en-
zymes were selected. For each restriction digestion reac-
tion, 5 μL of the amplified PCR product was digested with 
1.5 μL of restriction enzyme buffer, 0.5 μl (10 U) of the re-
striction enzyme MspI, and 8 μL of high-performance liq-
uid chromatography––grade water; the reaction mixture 
(15 μL) was incubated at 37°C for 120 min. Separation of 
the digested fragments was visualized on 2% agarose gel 
run in TBE buffer at 100 V for 45 min, and stained with 0.5 
μg ml-1 ethidium bromide.
3.5. Statistical Analysis
Study data were analyzed using the statistical program 
STATA (4905 Lakeway Drive College Station, Texas 77845 
USA-version 10) for Windows. 
4. Results
Molecular examinations showed oral Candida coloni-
zation in 69% (96/139) of the patients. C. albicans was the 
most frequently isolated species (82.2%), followed by C. 
glabrata (7.29%), C. parapsilosis and C. kefyr (both, 4.1%), and 
C. tropicalis (2%). The recognition site for the MspI enzyme 
is a CCGG sequence (12, 13). The molecular characteriza-
tion of Candida spp. was done on the basis of the number 
of digested DNA bands in the ITS region. Candida albicans, 
C. glabrata, C. krusei, C. tropicalis, and C. guilliermondii and 
produced 3 bands whereas the others showed 2 distinc-
tive bands after digestion with MspI (10). Size of the pre- 
and post-digestion ITS1–ITS4 PCR products for Candida 
spp. are reported in Table 1. The patterns obtained after 
MspI restriction digestion of the PCR products of Candida 
isolates are shown in Figure 1 and Figure 2. Table 2 shows 
the frequency of the isolation of clinically important Can-
dida spp. from HIV-positive patients in Kerman, Iran. The 
data clearly show the predominance of C. albicans (82.2%) 
among the other species. The demographic characteris-
tics of the study population were as follows. Out of a total 
of 139 HIV-positive patients, 125 were male (89.92%) and 14 
were female (10.07%); 61 patients were unmarried (43.88%) 
and 78 were married (56.11%). The mean of age of the study 
population was 36 ± 6 years. 
Size of ITS1–ITS4, 
bp
Size (s) of Restric-
tion Product (s), bp
C. albicans 535 297, 238
C. glabrata 871 557, 314
C. parapsilosis 520 520
C. krusei 510 261, 249
C. tropicalis 524 340, 184
C. guilliermondii 608 371, 155, 82
Table 1. Size of ITS1–ITS4 PCR Products for Candida spp. Before and After 
Digestion With MspI
          Frequency
No %
C. albicans 79 82.2
C. glabrata 7 7.29
C. parapsilosis 4 4.1
C. kefyr 4 4.1
C. tropicalis 2 2
Total 96 100
Table 2. . Frequency of Isolation of Clinically Important Candida spp. 
From HIV-Positive Patients in Kerman, Iran
Lane 1: molecular marker (M); lanes 2, 3, and 5 (samples 27, 28, and 30): 
Candida albicans; lane 4 (sample 29): C. glabrata.
Figure 1. Patterns of PCR Products of Candida Isolates After Digestion 
With the Restriction Enzyme MspI
Lane 1: molecular marker (M); lane 2 (sample 31): Candida kefyr; lanes 3, 
4, 5, and 7 (samples 32, 33, 34, and 36): C. albicans; lane 6 (sample 35): C. 
glabrata.
Figure 2. Patterns of PCR Products of Candida Isolates After Digestion 
With the Restriction Enzyme MspI
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5. Discussion
The incidence of opportunistic fungal infections such 
as candidiasis has considerably increased in recent years. 
Most of the clinically important fungi belong to the Can-
dida spp. (12). Early diagnosis of invasive fungal infec-
tions such as candidiasis is necessary to help clinicians 
administer better treatment decisions and increase the 
patients’ chance of survival. The ability of molecular 
biology methods to detect fungal pathogens is far su-
perior to that of traditional phenotyping methods (13, 
14). Therefore, in the recent past, a variety of molecular 
biology methods have been applied for the genetic iden-
tification of Candida spp. Some of these methods include 
standard PCR, multiplex PCR, PCR with species-specific 
probes, PCR-RFLP, real–time PCR (15), randomly amplified 
polymorphic DNA (RAPD)–PCR, DNA sequence analysis, 
and the mitochondrial large subunit ribosomal RNA 
(mtLsurRNA)mtLsurRNA gene Sequences (16-18).
In this study, we identified Candida spp. by PCR-RFLP 
method by using 2 universal primers, ITS1 and ITS4, and 
the restriction enzyme MspI. This method is rapid, easy, 
and reliable; the method can also be used in clinical 
laboratories to identify clinically important Candida spp. 
(12). The PCR-RFLP method has been used for the genetic 
identification of Candida spp. in other studies as well (10, 
19). Isogai et al. and Williams et al. used the restriction en-
zymes HaeIII and HaeIII, DdeI, and BfaI, respectively, after 
amplification of the ITS1–ITS4 regions, for the identifica-
tion of clinically important Candida spp (7, 20). MspI does 
not distinguish between C. albicans and C. dubliniensis, 2 
morphologically similar species of Candida. (13, 15).
Our study showed that C. albicans (82.2%) was the most 
frequently isolated species in HIV-positive patients tested 
in Kerman, Iran. Similar results were observed by Chien-
Ching in a Taiwanese population (21) and by Katiraee (9) 
and Shokohi (13, 14) in Iranian populations. Although C. 
albicans is the most frequently implicated pathogen in 
OPC, other Candida spp. are being increasingly associ-
ated with invasive candidiasis (14). The results of our 
study were different from those shown by Enweani et al. , 
Okungbowa et al. and Clark et al. (22, 23, 24). In a study on 
incidence of candidiasis in 103 asymptomatic female stu-
dents, Enweani et al. reported that C. guilliermondii was 
the most commonly isolated pathogen in women who 
used contraceptive drugs (22). Okungbowa et al. reported 
that the predominant species isolated in the genitouri-
nary tract, in their study, was C. glabrata (33.7%), whereas 
Clark et al. (23, 24) reported that the predominant species 
in cases of bloodstream infection was C. parapsilosis (57.8 
%, 22/33).
Drug abuse and sexual promiscuity may be important 
factors influencing the varied distribution frequency of 
Candida spp. across different age-groups and locations 
(23). Our findings suggest that PCR-RFLP is a simple, use-
ful, and reliable method for identification of Candida 
isolates in mycology laboratories. We showed that C. al-
bicans, C. glabrata, C. parapsilosis, C. kefyr, and C. tropicalis 
were the major species isolated from HIV-positive pa-
tients in southeastern Iran.
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